Global Amino Acid Metabolism Disorders Treatment Market by Manufacturers, Regions, Type and Application, Forecast to 2023

The key elements of an amino acid are carbon (C), hydrogen (H), oxygen (O), and nitrogen (N), although other elements are found in the side chains of certain amino acids. Some amino acids derivatives are used in pharmaceutical industry. They include 5-HTP (5-hydroxytryptophan) used for experimental treatment of depression, L-DOPA (L-dihydroxyphenylalanine) for Parkinson's treatment, and eflornithine drug that inhibits ornithine decarboxylase and used in the treatment of sleeping sickness. A metabolic disorder can happen when abnormal chemical reactions in the body alter the normal metabolic process. It can also be defined as inherited single gene anomaly, most of which are autosomal recessive.

Scope of the Report:
This report focuses on the Amino Acid Metabolism Disorders Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
In the global market, North America is projected to retain a leading position in the market by the end of 2025 reaching a valuation of over US$359 Mn. It is expected to be closely followed by Europe.
The worldwide market for Amino Acid Metabolism Disorders Treatment is expected to grow at a CAGR of roughly 5.1% over the next five years, will reach 1020 million US$ in 2023, from 750 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
GlaxoSmithKline
Pfizer
AMINO
Merck
Recordati
Koninklijke
Sanofi
Shine Star (Hubei) Biological Engineering
Kyowa Hakko Kirin

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Arginine
Folic Acid
Vitamin B6 & B12
Thiamine
Vitamin D
Betaine
Carglumic Acid
Saproterin Dihydrochloride
Others

Market Segment by Applications, can be divided into
Phenylketonuria
Maple Syrup Urine Disease
Argininosuccinic Acidemia
Citrullinemia
Homocystinuria

There are 15 Chapters to deeply display the global Amino Acid Metabolism Disorders Treatment market.
Chapter 1, to describe Amino Acid Metabolism Disorders Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Amino Acid Metabolism Disorders Treatment, with sales, revenue, and price of Amino Acid Metabolism Disorders Treatment, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Amino Acid Metabolism Disorders Treatment, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Amino Acid Metabolism Disorders Treatment market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Amino Acid Metabolism Disorders Treatment sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source